Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Idexx Laboratories (IDXX) stock in plain English

Free brief · no signupStart here
IDXXPublished Nov 19, 2026
Idexx Laboratories Inc
Healthcare · Diagnostics & Research
Manufactures diagnostic instruments, test kits, and software for companion animal veterinary practices.
Assets:
Global reference laboratory networkOperates over 80 centralized labs worldwide processing complex diagnostic samples.
Over 160,000 active analyzersPlaces chemistry and hematology instruments inside veterinary clinics across the world.
Global water microbiology testingSupplies regulatory testing supplies to public utilities across over one hundred countries.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

60
OPS ScoreOperating finances
Latest quote
-1.26%$689.65
$54.33B
46.5×
$4.66B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was IDXX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Idexx Laboratories (IDXX) do?

Idexx Laboratories Inc (IDXX) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Manufactures diagnostic instruments, test kits, and software for companion animal veterinary practices. Installs diagnostic hardware in veterinary clinics to secure recurring sales of proprietary testing consumables and. It is worth $54.33B on the market and sold $4.66B over the last year.

Market cap
$54.33B
P/E ratio
46.5×
Annual sales
$4.66B
Sector
Healthcare
Industry
Diagnostics & Research
Brief updated
Nov 19, 2026

Brands and businesses behind IDXX

  • Catalyst: An in-clinic chemistry analyzer that generates recurring revenue from proprietary single-use test slides.
  • SNAP: Single-use rapid diagnostic test kits that veterinarians buy continuously to screen pets for heartworm, Lyme, and other diseases.
  • ProCyte: An in-clinic hematology analyzer that earns recurring revenue through specialized reagent packs and routine blood counts.
  • VetConnect PLUS: A cloud diagnostic software platform that links in-clinic testing and outside reference lab data for animal clinics.
  • Colilert: A testing product line that sells enzyme-substrate test packs to municipal utilities for rapid bacterial water screening.
  • Cornerstone: A veterinary practice management software system that earns money through software subscriptions and support fees.

IDXX’s flags, in plain English

Each flag is a number from Idexx Laboratories’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Earns Its Keep

Earns 68.9% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.

Capital Works Hard

Earns 52.2% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.

Fat Margins

Profit margin of 25.4%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.

Priced for Perfection

Priced at 46.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

2 more green flags open with the free trial. Try it free for 7 days.

Questions about IDXX

How big is Idexx Laboratories?

Idexx Laboratories’ market cap is $54.33B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $4.66B: what customers paid the company over the last year, before any costs.

What is IDXX’s P/E ratio?

IDXX’s P/E ratio is 46.5×. Investors pay about 46.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with IDXX?

A drop in overall veterinary clinic visit volumes reduces demand for consumable diagnostic testing supplies and laboratory processing. That is one risk on Idexx Laboratories’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Idexx Laboratories’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. IDXX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card